Hence, the potent inhibition displayed by the compound NSC 119915 towards CDC25 could be suggestive of its possible activity even in melanoma, and therefore it was judged as an appropriate choice for studying its activity against melanoma cells. This evidence concerns the gene CDC25C and melanoma.